{
  "id": 20436917,
  "title": "HLTH 2026: GLP-1 costs remain a challenge. A new CVS study aims to identify the right price",
  "url": "https://urgent.news/2026/11/17/hlth-2026-glp-1-costs-remain-a-challenge-a-new-cvs-study-aims-to",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-11-17T11:39:51.000Z",
  "source": {
    "name": "Fierce Healthcare",
    "slug": "fierce-healthcare",
    "url": "https://www.fiercehealthcare.com/payers/hlth-2026-glp-1-costs-remain-challenge-new-cvs-study-aims-identify-right-price"
  },
  "original_language": "en",
  "account": null,
  "summary": "Cost and access to GLP-1s remains a challenge, but the benefits of these drugs aren't in doubt. A new study from CVS Health aims to quantify at what price a GLP-1 drug has generated enough savings elsewhere through improved clinical outcomes",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}